When hepatocellular carcinoma (HCC) is centrally adherent to major vessels, radiotherapy administered after surgery improves outcomes even in the setting of negative surgical margins, according to a ...
Adjuvant radiotherapy (RT) for early breast cancer protected against ipsilateral recurrence for 10 years after treatment but not thereafter, according to long-term follow-up from a randomized trial.
Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency Adults with locally advanced HNSCC planning to undergo surgery and PORT were randomly assigned 1:1 to ...
Please provide your email address to receive an email when new articles are posted on . Patients with advanced muscle-invasive bladder cancer had lower risk for local recurrence with adjuvant ...
Please provide your email address to receive an email when new articles are posted on . Radiotherapy after breast-conserving surgery for early breast cancer protected against recurrence for 10 years.
Adjuvant radiotherapy reduces the risk for short-term recurrence in patients with early breast cancer, but it may have no impact on long-term recurrence or overall survival, based on a 30-year ...
Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for ...
EAU 2026: Preliminary Results of a Phase II Study to Evaluate the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) in ...
Adjuvant radiation and endocrine therapy significantly reduce locoregional recurrence in early-stage breast cancer post-lumpectomy, especially in low-risk patients. Radiation therapy notably decreases ...
Results from the IDEA trial suggest that younger postmenopausal patients with breast cancer may skip adjuvant radiotherapy without increasing their risk of recurrence, as long as they meet certain ...
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma We evaluated 1,107 patients with pN1 prostate cancer treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results